| 000 | 01785 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516104531.0 | ||
| 264 | 0 | _c20130117 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a1768-3254 | ||
| 024 | 7 |
_a10.1016/j.ejmech.2012.07.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChen, Kuen-Feng | |
| 245 | 0 | 0 |
_aBlockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity. _h[electronic resource] |
| 260 |
_bEuropean journal of medicinal chemistry _cSep 2012 |
||
| 300 |
_a220-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzenesulfonates _xchemistry |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 | _aPhenylurea Compounds |
| 650 | 0 | 4 |
_aPhosphoproteins _xmetabolism |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xanalogs & derivatives |
| 650 | 0 | 4 |
_aProtein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aProtein Tyrosine Phosphatase, Non-Receptor Type 6 _xmetabolism |
| 650 | 0 | 4 |
_aPyridines _xchemistry |
| 650 | 0 | 4 |
_aSTAT3 Transcription Factor _xmetabolism |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aTai, Wei-Tien | |
| 700 | 1 | _aHsu, Cheng-Yi | |
| 700 | 1 | _aHuang, Jui-Wen | |
| 700 | 1 | _aLiu, Chun-Yu | |
| 700 | 1 | _aChen, Pei-Jer | |
| 700 | 1 | _aKim, InKi | |
| 700 | 1 | _aShiau, Chung-Wai | |
| 773 | 0 |
_tEuropean journal of medicinal chemistry _gvol. 55 _gp. 220-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejmech.2012.07.023 _zAvailable from publisher's website |
| 999 |
_c22006548 _d22006548 |
||